What does CUSIP G9495L109 represent in this 13F holders report?

CUSIP G9495L109 is the security identifier for VRAX - VIRAX BIOLABS GROUP LTD SHS NEW - Stock used to aggregate holder disclosures.

How many institutions held VRAX - VIRAX BIOLABS GROUP LTD SHS NEW - Stock in Q4 2023?

No institutional holders were reported for VRAX - VIRAX BIOLABS GROUP LTD SHS NEW - Stock in Q4 2023; review adjacent reporting periods for trend context.

VIRAX BIOLABS GROUP LTD SHS NEW - Stock (VRAX)

CUSIP: G9495L109

Q4 2023 13F Holders as of 31 Dec 2023

Security type / class: Equity / Stock
Total 13F shares: 0
Total 13F value: $0
Share change: -33,509
Number of holders: 0
Value change: -$10,891
Number of sells: 4

Security key

G9495L109

Report period

Q4 2023

Institutions

Top holders

VRAX full security history Newer quarter: Q3 2025 Virax Biolabs Group Ltd SEC filings Virax Biolabs Group Ltd company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP G9495L109

Newer quarter: Q3 2025

Recent filing periods:

Q2 2026 Q1 2026 Q4 2025 Q3 2025

There are no holders of VRAX - VIRAX BIOLABS GROUP LTD SHS NEW - Stock as of Q4 2023.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .